Research Topics
| J A MelnikowSummaryAffiliation: University of California Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Detection of high-grade cervical dysplasia: impact of age and Bethesda system terminologyJ Melnikow
Department of Family and Community Medicine, University of California, Davis 95817, USA
Diagn Cytopathol 17:321-5. 1997..Consideration of patient age and whether HPV is the only Pap smear finding may reduce referral for immediate colposcopy...- Cervical intraepithelial neoplasia outcomes after treatment: long-term follow-up from the British Columbia Cohort StudyJoy Melnikow
Department of Family and Community Medicine, Center for Healthcare Policy and Research, University of California Davis, Sacramento, CA 95817, USA
J Natl Cancer Inst 101:721-8. 2009..Information on the long-term risk of cervical intraepithelial neoplasia (CIN) recurrence among women treated for CIN is limited yet critical for evidence-based surveillance recommendations... - Tamoxifen for breast cancer risk reduction: impact of alternative approaches to quality-of-life adjustment on cost-effectiveness analysisJoy Melnikow
Department of Family and Community Medicine, University of California, Davis, Sacramento, California 95817, USA
Med Care 46:946-53. 2008..In cost-effectiveness analysis (CEA), the effects of health-care interventions on multiple health dimensions typically require consideration of both quantity and quality of life... - Chemoprevention: drug pricing and mortality: the case of tamoxifenJoy Melnikow
Department of Family and Community Medicine, University of California Davis, Sacramento, California 95817, USA
Cancer 107:950-8. 2006..Tamoxifen is a prototypic cancer chemopreventive agent, yet clinical trials have not evaluated its effect on mortality or the impact of drug pricing on its cost-effectiveness... - Preferences of Women Evaluating Risks of Tamoxifen (POWER) study of preferences for tamoxifen for breast cancer risk reductionJoy Melnikow
Department of Family and Community Medicine, University of California Davis, Sacramento, California 95817, USA
Cancer 103:1996-2005. 2005..The objective of this study was to understand the attitudes and preferences of risk-eligible women regarding use of tamoxifen for breast cancer risk reduction... - Management of the low-grade abnormal Pap smear: What are women's preferences?Joy Melnikow
Department of Family and Community Medicine, University of California, Davis, Sacramento 95817, USA
J Fam Pract 51:849-55. 2002..To evaluate preferences among ethnically diverse women for the management of a low-grade abnormal Pap smear result: early colposcopy or observation with repeat Pap smears... - Surveillance after treatment for cervical intraepithelial neoplasia: outcomes, costs, and cost-effectivenessJoy Melnikow
Department of Economics, Center for Healthcare Policy and Research, University of California, Davis, California 95817, USA
Obstet Gynecol 116:1158-70. 2010..To estimate outcomes and costs of surveillance strategies after treatment for high-grade cervical intraepithelial neoplasia (CIN)... - Natural history of cervical squamous intraepithelial lesions: a meta-analysisJ Melnikow
Department of Family and Community Medicine, University of California, Davis 95817, USA
Obstet Gynecol 92:727-35. 1998..To define the strengths and weaknesses of existing research on the natural history of cervical squamous intraepithelial lesions (SIL) and to estimate rates of progression and regression without treatment... - Do follow-up recommendations for abnormal Papanicolaou smears influence patient adherence?J Melnikow
Department of Family and Community Medicine, University of California Davis School of Medicine, Sacramento, USA
Arch Fam Med 8:510-4. 1999..To compare adherence to follow-up recommendations for colposcopy or repeated Papanicolaou (Pap) smears for women with previously abnormal Pap smear results... - Vaginal birth after cesarean in CaliforniaJ Melnikow
Department of Family and Community Medicine, University of California, Davis, Sacramento, California 95817, USA
Obstet Gynecol 98:421-6. 2001..To estimate rates at which women were offered and consented to trial of labor in California hospitals with high and low risk-adjusted cesarean delivery rates... - Put prevention into practice: a controlled evaluationJ Melnikow
Department of Family and Community Medicine, University of California, Davis, USA
Am J Public Health 90:1622-5. 2000..The purpose of this study was to evaluate whether Put Prevention Into Practice (PPIP) materials affected the delivery of 8 clinical preventive services... - Do personal and societal preferences differ by socio-demographic group?Peter Franks
Department of Family and Community Medicine, Center for Health Services Research in Primary Care, University of California, Sacramento, CA, USA
Health Econ 16:319-25. 2007..These preliminary findings suggest that using the EQ-5D Index in CEAs may not contribute to socio-demographic inequities... - Reporting number needed to treat and absolute risk reduction in randomized controlled trialsJim Nuovo
Department of Family and Community Medicine, University of California, Davis, 4860 Y St, Sacramento, CA 95817, USA
JAMA 287:2813-4. 2002..We examined the frequency of explicit reporting of the number needed to treat (NNT) and the absolute risk reduction (ARR) in RCTs... - Recruitment strategies for minority participation: challenges and cost lessons from the POWER interviewJanet Fulton Keyzer
Center for Health Services Research in Primary Care, University of California, Davis, Sacramento, CA 95817, USA
Ethn Dis 15:395-406. 2005..The importance of recruiting and retaining women from diverse populations is well recognized; however, the recruitment process often presents greater challenges at higher costs than initially anticipated... - "I'm going to die of something anyway": women's perceptions of tamoxifen for breast cancer risk reductionDebora A Paterniti
Center for Health Services Research in Primary Care, University of California, Davis, Sacramento, CA 95817, USA
Ethn Dis 15:365-72. 2005..To investigate how ethnically diverse women who are eligible for tamoxifen prophylaxis because of their breast cancer risk decide about tamoxifen use for risk reduction... - Networked for change? Identifying obstetric opinion leaders and assessing their opinions on caesarean deliveryRichard L Kravitz
Center for Health Services Research in Primary Care, University of California, Davis, 4150 V Street Suite 2500, Sacramento, CA 95817, USA
Soc Sci Med 57:2423-34. 2003..However, they did not consistently support policies designed to reduce the caesarean delivery rate. The results have implications for the generalizability of opinion leader strategies... - Cost-effectiveness of extending cervical cancer screening intervals among women with prior normal pap testsShalini L Kulasingam
Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, USA
Obstet Gynecol 107:321-8. 2006..We estimated the cost-effectiveness of screening women with 3 or more prior normal tests compared with screening those with no prior tests... - Risk of cervical cancer associated with extending the interval between cervical-cancer screeningsGeorge F Sawaya
Department of Obstetrics, Gynecology, and Reproductive Sciences, Department of Veterans Affairs and University of California, San Francisco, San Francisco, USA
N Engl J Med 349:1501-9. 2003.... - Conservative versus aggressive follow up of mildly abnormal Pap smears: testing for process utilityStephen Birch
Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Canada
Health Econ 12:879-84. 2003..We also found that relative preferences among different processes may depend on the particular circumstances or pathologies being considered... - Human papillomavirus triage of atypical squamous cells of undetermined significance: cost-effective, but at what cost?Joy Melnikow
J Natl Cancer Inst 98:82-3. 2006
Research Grants
- TAMOXIFEN & BREAST CANCER--ACCEPTANCE/COST EFFECTIVENESSJoy Melnikow; Fiscal Year: 2002..abstract_text> ..
- Surveillance Strategies Following Treatment for CINJoy Melnikow; Fiscal Year: 2007..Alternative strategies for post-treatment surveillance will be evaluated. ..